✦ LIBER ✦

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

✍ Scribed by V. PENGO; L. CRIPPA; A. FALANGA; G. FINAZZI; F. MARONGIU; M. MOIA; G. PALARETI; D. POLI; S. TESTA; E. TIRAFERRI; A. TOSETTO; A. TRIPODI; S. SIRAGUSA; C. MANOTTI

Book ID: 117961607
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 122 KB
Volume: 10
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2012.04866.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indirect comparison studies – are they u

Indirect comparison studies – are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation

✍ Skjøth, F.; Larsen, T. B.; Rasmussen, L. H. 📂 Article 📅 2012 🏛 Schattauer 🌐 English ⚖ 180 KB

Is there a need for adjusting the result

Is there a need for adjusting the results of the recent meta-analysis on the novel oral anticoagulants in atrial fibrillation to the baseline CHADS2 score?

✍ Rui Providência 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Oral direct thrombin inhibitor AZD0837 f

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB